Abbott Laboratories faces a criminal investigation by the Justice Department, after its recall of formulas due to complaints of bacterial infections exacerbated a shortage that began due to pandemic-induced supply chain issues.
The Justice Department was investigating conduct at Abbott’s plant in Sturgis, Michigan,
According to an Abbott spokesman, they are fully cooperating with the Justice Department without specifying what aspect of the company is under scrutiny.
In February 2022, Abbott, the biggest US supplier of baby formula, recalled Similac and other infant formula products produced at its Michigan facility after reports of bacterial infections in babies who had consumed products made there.
The US Food and Drug Administration found "shocking" results during an inspection, such as cracks in vital equipment, inadequate hand-washing, and evidence of previous bacterial contamination.
The plant has since reopened.


Samsung Shares Slide as Labor Talks Intensify Ahead of Planned Strike
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income
Arcadia Mayor Eileen Wang Pleads Guilty in China Foreign Agent Case
Trump Says Iran Ceasefire Near Collapse as Oil Prices Surge
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases
Trump to Visit China for Key U.S.-China Summit With Xi Jinping
Trump and IRS in Settlement Talks Over $10 Billion Tax Return Leak Lawsuit
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns
K+S Raises 2026 Earnings Outlook After Strong Q1 Results
Trump Administration Files Fraud Charges Against Southern Poverty Law Center Over Informant Payments
ECB Signals Possible Interest Rate Move if Inflation Outlook Fails to Improve
Trump-Xi China Summit 2026: Trade Tensions, Taiwan, and Iran Take Center Stage
Ibiden Stock Surges as AI Chip Demand Boosts Profit Outlook 



